Literature DB >> 20013706

[Vascular endothelial growth factor - structure, function and role in airways inflammation and the clinical course of asthma].

Krzysztof Gomułka1, Jerzy Liebhart.   

Abstract

Vascular endothelial growth factor (VEGF) is produced by a wide range of cells and plays an important role in normal and pathological angiogenesis. The formation of the vascular system is essential for inflammatory process in airways, especially in the course of chronic lung diseases - for example bronchial asthma. Increased level of VEGF in serum and induced sputum has been demonstrated in patients with stable asthma, as well as during the exacerbation of this disease. VEGF end VEGF-receptor's expressions is closely correlated with neovascularization and seems to be an important predictor of the lung's remodeling. Due to direct causative relationship between inflammatory process and angiogenesis in airways, it was suggested, that inhibiting VEGF's activity would have an anti-inflammatory effect on airways. In this article the potential role of vascular endothelial growth factor in airways inflammation, remodeling and the clinical course of bronchial asthma is presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013706

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  3 in total

1.  Vascular endothelial growth factor-activated basophils in asthmatics.

Authors:  Krzysztof Gomułka; Jerzy Liebhart; Andrzej Lange; Wojciech Mêdrala
Journal:  Postepy Dermatol Alergol       Date:  2020-06-25       Impact factor: 1.837

2.  Increased hypoxia-inducible factor 1α expression in lung cells of horses with recurrent airway obstruction.

Authors:  Marie Toussaint; Laurence Fievez; Christophe J Desmet; Dimitri Pirottin; Frédéric Farnir; Fabrice Bureau; Pierre Lekeux
Journal:  BMC Vet Res       Date:  2012-05-23       Impact factor: 2.741

3.  Analysis of growth factors in serum and induced sputum from patients with asthma.

Authors:  Hui Zou; Qiu-Hong Fang; Ying-Min Ma; Xue-Yan Wang
Journal:  Exp Ther Med       Date:  2014-06-04       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.